◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Innovator Equity Dual Directional 10 Buffer ETF - February (DDTF) ETF Overview

Name: Innovator Equity Dual Directional 10 Buffer ETF - February (DDTF) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · Defined Outcome · DATA UPDATED 2026-08-31

Innovator Equity Dual Directional 10 Buffer ETF - February (DDTF) is an exchange-traded fund managed by Innovator ETFs in the "Defined Outcome" category. It manages roughly $20 million in assets.

The fund has adopted a policy pursuant to Rule 35d-1 under the 1940 Act to invest, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in investments that provide exposure to the SPDR® S&P 500® ETF Trust. It is non-diversified.

Interactive chart & fund stats →

DDTF Fund Statistics

Expense ratio	0.79%
Assets under management	$20 million
Fund category	Defined Outcome
Fund family	Innovator ETFs
Inception	2026-01-30

The live price chart, fund profile and news are in the interactive DDTF viewer.

Other Companies in Defined Outcome

DDTS · Innovator Equity Dual Directional 10 Buffer ETF - September — $20 million
QTJA · Innovator Growth Accelerated Plus ETF - January — $20 million
QTAP · Innovator Growth-100 Accelerated Plus ETF – April — $20 million
DLNV · FT Vest U.S. Equity Dual Directional Buffer ETF November — $20 million
QTJL · Innovator Growth Accelerated Plus ETF - July — $19 million
XMAY · FT Vest U.S. Equity Enhance & Moderate Buffer ETF - May — $19 million
OCTJ · Innovator Premium Income 30 Barrier ETF - October — $19 million
OCTH · Innovator Premium Income 20 Barrier ETF - October — $18 million

← DDTD All “D” companies DDTG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.